pgxp
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
pgxp [2024/11/04 12:08] trynke |
pgxp [2025/08/12 16:40] (current) petra_vinke |
||
|---|---|---|---|
| Line 23: | Line 23: | ||
| * A total of n=~620 participants completed all the steps and received their personal information in the app.\\ | * A total of n=~620 participants completed all the steps and received their personal information in the app.\\ | ||
| * As a final step, all ~1150 respondents to the baseline PGxP questionnaire received a follow-up questionnaire containing questions on their decision-making process, opinion on the shared information and on the app, and the actual use of the PGxP (if applicable). | * As a final step, all ~1150 respondents to the baseline PGxP questionnaire received a follow-up questionnaire containing questions on their decision-making process, opinion on the shared information and on the app, and the actual use of the PGxP (if applicable). | ||
| + | |||
| + | ===== Publications ===== | ||
| + | |||
| + | The following publication was based on the PGXP Assessment: | ||
| + | |||
| + | * Lanting et al. (2025) [[https://www.cell.com/ajhg/abstract/S0002-9297(25)00102-8|Low-cost generation of clinical-grade, layperson-friendly pharmacogenetic passports using oligonucleotide arrays]]. AJHG 112(5): P1015-1028 | ||
pgxp.1730718510.txt.gz ยท Last modified: 2025/02/05 14:49 (external edit)
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
